4//SEC Filing
Velleca Mark A. 4
Accession 0001415889-24-003963
CIK 0001701541other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:35 PM ET
Size
5.6 KB
Accession
0001415889-24-003963
Insider Transaction Report
Form 4
Velleca Mark A.
DirectorPRESIDENT & CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-02-14+537,000→ 537,000 totalExercise: $4.86Exp: 2034-02-13→ Common Stock (537,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 14, 2025, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001706847
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:35 PM ET
- Size
- 5.6 KB